The impact of structural uncertainty on cost-effectiveness models for adjuvant endocrine breast cancer treatments: The need for disease-specific model standardization and improved guidance

Gerardus W.J. Frederix, Johan G.C. Van Hasselt, Jan H.M. Schellens, Anke M. Hövels, Jan A.M. Raaijmakers, Alwin D.R. Huitema, Johan L. Severens

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

29 Citaten (Scopus)

Vingerafdruk

Duik in de onderzoeksthema's van 'The impact of structural uncertainty on cost-effectiveness models for adjuvant endocrine breast cancer treatments: The need for disease-specific model standardization and improved guidance'. Samen vormen ze een unieke vingerafdruk.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology